Clinical trial
Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small…
NCT00200382 · Rasim Gucalp, Other · Terminated
Key facts
| NCT number | NCT00200382 |
|---|---|
| Title | Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer |
| Official title | Phase II Study to Evaluate the Efficacy and Safety of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer |
| Lead sponsor | Rasim Gucalp, Other |
| Collaborators | Millennium Pharmaceuticals, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | PS-341 (Velcade-drug) |
| Enrollment | 27 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: